Progenics Pharmaceuticals
(PGNX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2017 | 06-2017 | 03-2017 | 12-2016 | 09-2016 | |
| Sales | 2,697 | 2,765 | 2,347 | 4,653 | 53,850 |
| Gross Profit | 2,697 | 2,765 | 2,347 | 4,653 | 53,850 |
| Operating Expenses | 17,002 | 18,325 | 17,600 | 9,325 | 17,647 |
| Operating Income | -14,305 | -15,560 | -15,253 | -4,672 | 36,203 |
| Interest Expense | 1,047 | 1,076 | 0 | 0 | 0 |
| Other Income | 0 | 0 | -1,107 | -703 | 79 |
| Pre-tax Income | -15,352 | -16,636 | -16,360 | -5,375 | 36,282 |
| Net Income Continuous | -15,352 | -16,636 | -16,360 | -7,219 | 36,282 |
| Minority Interests | N/A | N/A | N/A | -15 | -21 |
| Net Income | $-15,352 | $-16,636 | $-16,360 | $-7,204 | $36,303 |
| EPS Basic Total Ops | -0.22 | -0.24 | -0.23 | -0.11 | 0.52 |
| EPS Basic Continuous Ops | -0.22 | -0.24 | -0.23 | -0.10 | 0.52 |
| EPS Diluted Total Ops | -0.22 | -0.24 | -0.23 | -0.11 | 0.52 |
| EPS Diluted Continuous Ops | -0.22 | -0.24 | -0.23 | -0.10 | 0.52 |
| EBITDA(a) | $-14,017 | $-15,272 | $-14,997 | $-4,454 | $36,565 |